Elevance Health, Inc.
ELV
$428.79
$1.920.45%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 12.80% | -1.57% | |||
| Total Other Revenue | -14.49% | 11.37% | |||
| Total Revenue | 7.59% | 0.66% | |||
| Cost of Revenue | 5.41% | 1.67% | |||
| Gross Profit | 13.71% | -2.08% | |||
| SG&A Expenses | -4.57% | 6.75% | |||
| Depreciation & Amortization | -13.89% | 47.54% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.91% | 2.99% | |||
| Operating Income | 218.24% | -50.15% | |||
| Income Before Tax | 361.55% | -55.86% | |||
| Income Tax Expenses | 217.62% | -47.12% | |||
| Earnings from Continuing Operations | 428.81% | -59.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -120.00% | -37.50% | |||
| Net Income | 422.25% | -58.86% | |||
| EBIT | 218.24% | -50.15% | |||
| EBITDA | 153.72% | -40.02% | |||
| EPS Basic | 433.10% | -58.72% | |||
| Normalized Basic EPS | 335.64% | -61.17% | |||
| EPS Diluted | 431.32% | -58.52% | |||
| Normalized Diluted EPS | 334.11% | -60.97% | |||
| Average Basic Shares Outstanding | -2.03% | -0.34% | |||
| Average Diluted Shares Outstanding | -1.69% | -0.86% | |||
| Dividend Per Share | 4.91% | 0.00% | |||
| Payout Ratio | -0.80% | 1.40% | |||